NO20034874L - Aerosolformuleringer for pulmonaradministrasjon av medikamenter for frembringelse av en systemisk effekt - Google Patents
Aerosolformuleringer for pulmonaradministrasjon av medikamenter for frembringelse av en systemisk effektInfo
- Publication number
- NO20034874L NO20034874L NO20034874A NO20034874A NO20034874L NO 20034874 L NO20034874 L NO 20034874L NO 20034874 A NO20034874 A NO 20034874A NO 20034874 A NO20034874 A NO 20034874A NO 20034874 L NO20034874 L NO 20034874L
- Authority
- NO
- Norway
- Prior art keywords
- drugs
- produce
- pulmonary administration
- aerosol formulations
- systemic effect
- Prior art date
Links
- 239000000443 aerosol Substances 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 230000002685 pulmonary effect Effects 0.000 title 1
- 230000009885 systemic effect Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Dispersion Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP02004786A EP1340492A1 (en) | 2002-03-01 | 2002-03-01 | Aerosol formulations for pulmonary administration of medicaments having systemic effects |
| PCT/EP2003/001962 WO2003074023A1 (en) | 2002-03-01 | 2003-02-26 | Aerosol formulations for pulmonary administration of medicaments to produce a systemic effect |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20034874D0 NO20034874D0 (no) | 2003-10-31 |
| NO20034874L true NO20034874L (no) | 2003-12-23 |
Family
ID=27675679
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20034874A NO20034874L (no) | 2002-03-01 | 2003-10-31 | Aerosolformuleringer for pulmonaradministrasjon av medikamenter for frembringelse av en systemisk effekt |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US20050129621A1 (pl) |
| EP (2) | EP1340492A1 (pl) |
| JP (1) | JP2005519094A (pl) |
| KR (1) | KR20040091050A (pl) |
| CN (2) | CN1638731A (pl) |
| AR (2) | AR038643A1 (pl) |
| AT (1) | ATE488224T1 (pl) |
| AU (1) | AU2003215597B2 (pl) |
| BR (1) | BR0303348A (pl) |
| CA (1) | CA2477879C (pl) |
| DE (1) | DE60334973D1 (pl) |
| EA (1) | EA008571B1 (pl) |
| ES (1) | ES2358293T3 (pl) |
| GE (1) | GEP20063985B (pl) |
| HR (1) | HRP20040751A2 (pl) |
| IL (1) | IL163842A0 (pl) |
| MA (1) | MA27107A1 (pl) |
| MX (1) | MXPA04008370A (pl) |
| NO (1) | NO20034874L (pl) |
| NZ (1) | NZ535019A (pl) |
| PE (1) | PE20030949A1 (pl) |
| PL (1) | PL372261A1 (pl) |
| TN (1) | TNSN04148A1 (pl) |
| TW (1) | TW200304833A (pl) |
| UA (2) | UA81238C2 (pl) |
| WO (1) | WO2003074023A1 (pl) |
| ZA (3) | ZA200406918B (pl) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010031244A1 (en) * | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
| IT1303788B1 (it) * | 1998-11-25 | 2001-02-23 | Chiesi Farma Spa | Formulazioni di aerosol medicinali. |
| DZ2947A1 (fr) | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
| US6315985B1 (en) * | 1999-06-18 | 2001-11-13 | 3M Innovative Properties Company | C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability |
| IT1317720B1 (it) * | 2000-01-07 | 2003-07-15 | Chiesi Farma Spa | Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani. |
| IT1318514B1 (it) * | 2000-05-12 | 2003-08-27 | Chiesi Farma Spa | Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari. |
| US20060257324A1 (en) * | 2000-05-22 | 2006-11-16 | Chiesi Farmaceutici S.P.A. | Pharmaceutical solution formulations for pressurised metered dose inhalers |
| EE05167B1 (et) * | 2000-05-22 | 2009-06-15 | Chiesi Farmaceutici S.P.A. | Stabiilsed farmatseutilised lahuspreparaadid survestatud doseerivatele inhalaatoritele |
| ES2222294T3 (es) * | 2001-07-02 | 2005-02-01 | Chiesi Farmaceutici S.P.A. | Formulacion optimizada de tobramicina para administracion en forma de aerosol. |
| ME00077B (me) * | 2002-03-01 | 2010-06-10 | Chiesi Farm Spa | Formoterol najfiniji preparat |
| EP1415647A1 (en) * | 2002-10-23 | 2004-05-06 | CHIESI FARMACEUTICI S.p.A. | "Long-acting beta-2 agonists ultrafine formulations" |
| EP1452179A1 (en) * | 2003-02-27 | 2004-09-01 | CHIESI FARMACEUTICI S.p.A. | Novel medicament combination of a highly potent long-lasting beta2-agonist and a corticosteroid |
| GB0311701D0 (en) * | 2003-05-21 | 2003-06-25 | Karib Kemi Pharm Liited | Improved metered dose inhaler product |
| KR20060117909A (ko) * | 2003-09-15 | 2006-11-17 | 벡투라 리미티드 | 폐 흡입에 의한 조루 치료용 제약학적 조성물 |
| EP1595531A1 (en) | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
| IL177103A0 (en) * | 2004-02-27 | 2006-12-10 | Chiesi Farma Spa | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
| BRPI0512878A (pt) * | 2004-07-02 | 2008-04-15 | Boehringer Ingelheim Int | formulações de suspensão de aerossol, com tg 227 ea ou tg 134 a como agente propulsor |
| RU2457832C2 (ru) * | 2005-09-25 | 2012-08-10 | Сипла Лимитед | Состав на основе тровентола |
| WO2007076053A2 (en) * | 2005-12-21 | 2007-07-05 | Nitrox, Llc | Stable s-nitrosothiol formulations |
| DE102006017320A1 (de) * | 2006-04-11 | 2007-10-18 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel |
| EP2011534A1 (en) * | 2007-07-03 | 2009-01-07 | CHIESI FARMACEUTICI S.p.A. | Metered dose inhaler actuator |
| PE20090907A1 (es) * | 2007-07-21 | 2009-08-05 | Boehringer Ingelheim Int | Nuevos medicamentos pulverulentos que contienen tiotropio y salmeterol, asi como lactosa como excipiente |
| WO2009049159A1 (en) | 2007-10-10 | 2009-04-16 | Parion Sciences, Inc. | Delivering osmolytes by nasal cannula |
| US8555875B2 (en) * | 2008-12-23 | 2013-10-15 | Map Pharmaceuticals, Inc. | Inhalation devices and related methods for administration of sedative hypnotic compounds |
| MX336260B (es) * | 2010-07-12 | 2016-01-13 | Xellia Pharmaceuticals Aps | Composiciones para el tratamiento de infecciones de pulmon, formuladas para ser administrables mediante aerolizacion, y que incluyen tobramicina. |
| WO2012039741A1 (en) | 2010-09-22 | 2012-03-29 | The Board Of Regents Of The University Of Texas System | Novel block copolymer and micelle compositions and methods of use thereof |
| EP2717855A4 (en) | 2011-06-07 | 2014-11-12 | Parion Sciences Inc | Methods of Treatment |
| US8945605B2 (en) * | 2011-06-07 | 2015-02-03 | Parion Sciences, Inc. | Aerosol delivery systems, compositions and methods |
| US20130156823A1 (en) * | 2011-12-20 | 2013-06-20 | MAP Pharmacauticals, Inc. | Excipient-free Aerosol Formulation |
| GB201402513D0 (en) * | 2014-02-13 | 2014-04-02 | Cardiff Scintigraphics Ltd | Pressurised metered dose inhalers and method of manufacture |
| EP3160445B1 (en) | 2014-06-26 | 2021-10-20 | Island Breeze Systems Ca, LLC | Mdi related products and methods of use |
| EP3297710A4 (en) * | 2015-05-21 | 2019-05-01 | Island Breeze Systems Ca, LLC | DRILL-BASED INGREDIENTS WITH APPROPRIATE DOSE AND FOOD APPLICATORS AND APPLICATORS |
| US11129848B2 (en) | 2017-08-08 | 2021-09-28 | Perricone Hydrogen Water Company, Llc | Medication enhancement using hydrogen |
| GB201912686D0 (en) * | 2019-09-04 | 2019-10-16 | Reown Pharma Inc | Pharmaceutical composition |
| US11123365B2 (en) | 2019-11-18 | 2021-09-21 | Perricone Hydrogen Water Company, Llc | Compositions comprising palmitoylethanolamide and hydrogen water, and methods thereof |
| JP2024515446A (ja) * | 2021-03-23 | 2024-04-10 | １２３２１７６ ビー．シー． リミテッド | アナフィラキシーを処置するためのデバイス |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998024420A1 (en) * | 1996-12-04 | 1998-06-11 | Bioglan Ireland (R & D) Limited | Pharmaceutical compositions and devices for their administration |
| GB2326334A (en) * | 1997-06-13 | 1998-12-23 | Chiesi Farma Spa | Pharmaceutical aerosol compositions |
| US20010031244A1 (en) * | 1997-06-13 | 2001-10-18 | Chiesi Farmaceutici S.P.A. | Pharmaceutical aerosol composition |
| US6309623B1 (en) * | 1997-09-29 | 2001-10-30 | Inhale Therapeutic Systems, Inc. | Stabilized preparations for use in metered dose inhalers |
| US6284282B1 (en) * | 1998-04-29 | 2001-09-04 | Genentech, Inc. | Method of spray freeze drying proteins for pharmaceutical administration |
| DZ2947A1 (fr) * | 1998-11-25 | 2004-03-15 | Chiesi Farma Spa | Inhalateur à compteur de dose sous pression. |
| IT1303788B1 (it) * | 1998-11-25 | 2001-02-23 | Chiesi Farma Spa | Formulazioni di aerosol medicinali. |
| IT1317904B1 (it) * | 1999-09-11 | 2003-07-15 | Glaxo Group Ltd | Formulazione farmaceutica di propionato di fluticasone. |
| IT1317720B1 (it) * | 2000-01-07 | 2003-07-15 | Chiesi Farma Spa | Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani. |
| IT1317846B1 (it) * | 2000-02-22 | 2003-07-15 | Chiesi Farma Spa | Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva. |
| CZ303537B6 (cs) * | 2000-03-09 | 2012-11-21 | Gw Pharma Limited | Použití konopí pri príprave farmaceutické formulace a pumpickové sprejové zarízení |
| BR0005797A (pt) * | 2000-03-20 | 2001-10-16 | Abbott Lab | Métodos para o tratamento de disfunção sexual com apomorfina em nìveis de concentração plasmática especificados |
| IT1318514B1 (it) * | 2000-05-12 | 2003-08-27 | Chiesi Farma Spa | Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari. |
| EE05167B1 (et) * | 2000-05-22 | 2009-06-15 | Chiesi Farmaceutici S.P.A. | Stabiilsed farmatseutilised lahuspreparaadid survestatud doseerivatele inhalaatoritele |
| ME00077B (me) * | 2002-03-01 | 2010-06-10 | Chiesi Farm Spa | Formoterol najfiniji preparat |
| EP1595531A1 (en) * | 2004-05-13 | 2005-11-16 | CHIESI FARMACEUTICI S.p.A. | Stable pharmaceutical solution formulations for pressurized metered dose inhalers |
-
2002
- 2002-03-01 EP EP02004786A patent/EP1340492A1/en not_active Withdrawn
-
2003
- 2003-02-26 NZ NZ535019A patent/NZ535019A/en unknown
- 2003-02-26 UA UA20040806744A patent/UA81238C2/uk unknown
- 2003-02-26 EA EA200401006A patent/EA008571B1/ru not_active IP Right Cessation
- 2003-02-26 AT AT03743339T patent/ATE488224T1/de active
- 2003-02-26 MX MXPA04008370A patent/MXPA04008370A/es unknown
- 2003-02-26 US US10/505,679 patent/US20050129621A1/en not_active Abandoned
- 2003-02-26 GE GEAP8390A patent/GEP20063985B/en unknown
- 2003-02-26 CN CNA038049775A patent/CN1638731A/zh active Pending
- 2003-02-26 AU AU2003215597A patent/AU2003215597B2/en not_active Ceased
- 2003-02-26 PL PL03372261A patent/PL372261A1/pl not_active Application Discontinuation
- 2003-02-26 HR HRP20040751 patent/HRP20040751A2/hr not_active Application Discontinuation
- 2003-02-26 EP EP03743339A patent/EP1480616B1/en not_active Expired - Lifetime
- 2003-02-26 IL IL16384203A patent/IL163842A0/xx unknown
- 2003-02-26 ES ES03743339T patent/ES2358293T3/es not_active Expired - Lifetime
- 2003-02-26 BR BR0303348-1A patent/BR0303348A/pt not_active IP Right Cessation
- 2003-02-26 DE DE60334973T patent/DE60334973D1/de not_active Expired - Lifetime
- 2003-02-26 JP JP2003572543A patent/JP2005519094A/ja active Pending
- 2003-02-26 KR KR10-2004-7012649A patent/KR20040091050A/ko not_active Ceased
- 2003-02-26 CA CA2477879A patent/CA2477879C/en not_active Expired - Fee Related
- 2003-02-26 WO PCT/EP2003/001962 patent/WO2003074023A1/en not_active Ceased
- 2003-02-27 CN CNA2009100074339A patent/CN101502500A/zh active Pending
- 2003-02-27 UA UA20040806968A patent/UA80695C2/uk unknown
- 2003-02-27 TW TW092104190A patent/TW200304833A/zh unknown
- 2003-02-28 PE PE2003000200A patent/PE20030949A1/es not_active Application Discontinuation
- 2003-02-28 AR ARP030100686A patent/AR038643A1/es unknown
- 2003-10-31 NO NO20034874A patent/NO20034874L/no not_active Application Discontinuation
-
2004
- 2004-08-06 TN TNP2004000148A patent/TNSN04148A1/en unknown
- 2004-08-09 MA MA27816A patent/MA27107A1/fr unknown
- 2004-08-31 ZA ZA200406918A patent/ZA200406918B/xx unknown
- 2004-08-31 ZA ZA200406919A patent/ZA200406919B/en unknown
- 2004-08-31 ZA ZA200406917A patent/ZA200406917B/xx unknown
-
2015
- 2015-08-19 AR ARP150102671A patent/AR101593A2/es not_active Application Discontinuation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20034874D0 (no) | Aerosolformuleringer for pulmonaradministrasjon av medikamenter for frembringelse av en systemisk effekt | |
| NO20033343D0 (no) | Farmasöytiske doseringsformer av epothiloner for oral administrasjon | |
| NO20043866L (no) | Farmasoytisk formulering av IRESSA omfattende et vannopploselig cellulosederivat | |
| FI7617U1 (fi) | Amorfisen aktiivisen ainesosan stabiloitu farmaseuttinen valmiste | |
| IS7612A (is) | Staðbundin lyfjablanda | |
| NO20042842L (no) | Farmasoytiske formuleringer av platina-derivat | |
| FR2847253B1 (fr) | Nouveaux derives de pyridazinones a titre de medicaments et compositions pharmaceutiques les renfermant | |
| EP1435894A4 (en) | CYTOPROTECTIVE COMPOUNDS, PHARMACEUTICAL AND COSMETIC FORMULATIONS AND METHOD | |
| EE200200439A (et) | Tsentraalsete kannabinoidiretseptorite antagonisti kasutamine ravimtoodete valmistamiseks, aitamaksloobuda tubakatarbimisest | |
| AU2001231000A1 (en) | Dry powder formulations of antihistamine for nasal administration | |
| EP1646276A4 (en) | SPRAY FOR THE PRODUCTION OF A MEDICAMENT IN AEROSOL FORM | |
| NO20025592L (no) | Kontinuerlig produksjon av farmasöytisk granulering | |
| DK1399127T3 (da) | Olopatadinformuleringer til topisk administration | |
| PT1501534E (pt) | Formulacoes farmaceuticas | |
| HRP20040545A2 (en) | Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability | |
| CY2018005I2 (el) | Απο του στοματος φαρμακοτεχνικες μορφες της κλαντριβινης | |
| NO20035438L (no) | Farmasoytisk formulering for effektiv administrering av apomorfin, 6aR-(-)-N-propyl-norapomorfin og deres derivater og prodrugs derav | |
| NO20030418D0 (no) | Nytt farmasöytisk preparat | |
| NO20014738L (no) | Tolperisonholdig farmasöytisk preparat for oral administrering | |
| NO20043832L (no) | Oral fast losningsformulering av en darlig vannloselig aktiv substans | |
| EE200300501A (et) | Ninna manustatavad imidasotriasinooni sisaldavad kompositsioonid | |
| NO20025394D0 (no) | Formuleringer inneholdende et glukokorticoid legemiddel for behandling av bronkopulmonire sykdommer | |
| DK1225902T3 (da) | Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden | |
| FI20000780L (fi) | Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi | |
| NO20084860L (no) | Stabile farmasøytiske preparater av 2-aza-bisyklo-[3,3,0]-oktan-3-karboksylsyrederivater |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |